33 results on '"Iloeje, U.H."'
Search Results
2. Structured review of patient-reported outcome instruments for assessing patients with atrial fibrillation
3. 40 SEROCLEARANCE OF HBVDNA PREDICTS SIGNIFICANTLY REDUCED RISK OF HEPATOCELLULAR CARCINOMA AMONG THOSE WITH HIGH VIRAL LOADS: A TIME-DEPENDENT ANALYSIS OF SERIALLY MEASURED BIOMARKERS
4. 419 QUANTITATIVE SERUM HEPATITIS B SURFACE ANTIGEN IMPROVES PREDICTABILITY OF HBVDNA SEROCLEARANCE BUT NOT HBeAg SEROCLEARANCE IN CHRONIC HEPATITIS B PATIENTS
5. PDB8 Weight Loss of ≥3% of Body Weight After Initiating New Anti-Diabetic Therapy is Associated With Glycemic Control at 6 Months in Patients With Type 2 Diabetes
6. 462 PREDICTION OF LIVER CIRRHOSIS RISK BY LONG-TERM CHANGES IN SERUM LEVELS OF HBV DNA AND ALANINE AMINOTRANSFERASE
7. 473 DEVELOPMENT OF PREDICTION MODELS FOR HBV-RELATED LIVER CIRRHOSIS BY INTEGARTING HBV GENOTYPE AND SERUM LEVELS OF HBV DNA AND HBSAG
8. 475 DIFFERENCES IN THE ROLE OF QUANTITATIVE HEPATITIS B SURFACE ANTIGEN BETWEEN HBEAG SEROPOSITIVE AND SERONEGATIVE INDIVIDUALS WITH CHRONIC HEPATITIS B
9. 461 INTEGRATING QUANTITIATIVE SERUM HBSAG LEVELS INTO RISK SCORES FOR PREDICTING HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS
10. 68 SEROCLEARANCE OF HBVDNA IS THE MOST IMPORTANT PREDICTOR FOR THE REDUCED RISK OF HEPATOCELLULAR CARCINOMA: A TIME-DEPENDENT ANALYSIS OF LONG-TERM SERIALLY MEASURED BIOMARKERS
11. 12 INCIDENCE AND DETERMINANTS OF SPONTANEOUS DECLINE OF HBV DNA TO UNDETECTABLE LEVEL IN PATIENTS WITH HIGH VIRAL LOAD
12. 722 INCIDENCE AND DETERMINANTS OF SPONTANEOUS HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE: A COMMUNITY-BASED LONG-TERM FOLLOW-UP STUDY
13. 20 ENTECAVIR MAINTAINS A HIGH GENETIC BARRIER TO HBV RESISTANCE THROUGH 6 YEARS IN NAIVE PATIENTS
14. 919 ENTECAVIR (ETV) THERAPY IN CHRONIC HEPATITIS B PATIENTS PREVIOUSLY TREATED WITH ADEFOVIR (ADV) WITH INCOMPLETE RESPONSE ON-TREATMENT OR RELAPSE OFF-TREATMENT
15. 385 ASSOCIATION BETWEEN HBV REPLICATION AND SERUM ALT CHANGES IS NOT DEPENDENT ON HBV GENOTYPE AND MUTANTS
16. 384 RISK AND PREDICTORS OF HCC IN PEOPLE LESS THAN 40 YEARS OF AGE: UPDATE FROM THE REVEAL HBV STUDY
17. 644 LIVER DISEASE PROGRESSION IN CHRONIC HEPATITIS B INFECTED PERSONS WITH NORMAL SERUM ALANINE AMINO TRANSFERASE LEVEL: UPDATE FROM THE R.E.V.E.A.L.-HBV STUDY
18. 656 NEGATIVE CORRELATION BETWEEN HEPATITIS B AND HEPATITIS C VIRAL LOAD IN CO-INFECTED PERSONS
19. 141 SERIAL MONITORING OF VIRAL LOAD AND SERUM ALANINE AMINOTRANFERASE LEVEL AND THE RISK OF HEPATOCELLULAR CARCINOMA (HCC): R.E.V.E.A.L.-HBV STUDY UPDATE
20. [426] THE ASSOCIATION BETWEEN GENOTYPE AND HEPATITIS B VIRAL LOAD MAY DEPEND ON HBeAg SEROSTATUS: THE R.E.V.E.A.L.-HBV STUDY
21. [222] RISK OF LIVER CIRRHOSIS ASSOCIATED WITH GENOTYPE AND MUTANTS OF HEPATITIS B VIRUS
22. [475] A RISK FUNCTION NOMOGRAM FOR PREDICTING HCC IN PATIENTS WITH CHRONIC HEPATITIS B: THE REVEAL.-HBV STUDY
23. [474] FACTORS ASSOCIATED WITH SEROCLEARANCE OF HEPATITIS B e ANTIGEN: A LONG-TERM FOLLOW-UP STUDY
24. P.062 Excess mortality associated with chronic hepatitis B virus infection: the R.E.V.E.A.L.-HBV study
25. PCV117 - Structured review of patient-reported outcome instruments for assessing patients with atrial fibrillation
26. PDB67 - Associations Between Claims Based Adherence, Weight Loss And, Glycemic Control In Patients With Type 2 Diabetes
27. Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study.
28. PDB67 Associations Between Claims Based Adherence, Weight Loss And, Glycemic Control In Patients With Type 2 Diabetes
29. PCV117 Structured review of patient-reported outcome instruments for assessing patients with atrial fibrillation
30. Continuing Medical Education Exams 4: March 2006: Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load.
31. 497 Modeling clinical benefits of suppressing viral replication in HBeAg-negative chronic hepatitis B (CHB) patients: A number-needed-to-treat (NNT) analysis of entecavir and adefovir
32. 489 Predicting liver disease complications (HCC and cirrhosis) in patients with chronic hepatitis B infection using a risk function model: The R.E.V.E.A.L.-HBV study
33. 457 Determinants of hepatitis B viral load and its decline over time: A community-based follow-up study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.